Statins and chronic heart failure: do we need a large-scale outcome trial?
- 15 May 2002
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (10) , 1567-1573
- https://doi.org/10.1016/s0735-1097(02)01827-2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Effect of Carvedilol on Survival in Severe Chronic Heart FailureNew England Journal of Medicine, 2001
- Coronary artery disease as the cause of incident heart failure in the populationEuropean Heart Journal, 2001
- Baseline demographics of the Valsartan Heart Failure TrialEuropean Journal of Heart Failure, 2000
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF)The Lancet, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The effects of simvastatin on the incidence of heart failure in patients with coronary heart diseaseJournal of Cardiac Failure, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992